91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

2nd Symposium on Medicinal 91AV for Global Health

18 June 2017 14:30 - 21 June 2017 16:00, Madrid, Spain


Introduction
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (e.g. dengue, West Nile), kinetoplastids (e.g. Chagas disease, leishmaniasis) and parasitic worms (e.g. filariasis), remain a cause of high mortality across the globe. However, an ever-improving understanding of the complex life-cycles of the disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems. 
This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst showcasing the opportunity for creativity and innovation.
Speakers
  • Dr Ann Mills Duggan Wellcome Trust, United Kingdom
  • Prof Matt Todd University of Sydney, Australia
  • Dr Julian Rayner Wellcome Trust Sanger Institute, United Kingdom
  • Dr Ben Perry DNDi , Switzerland
  • Prof Chris Abell University of Cambridge, United Kingdom
  • Prof Carl Nathan Weill Cornell Medical College, United States
  • Dr Evelyne Fontaine Sanofi, France
  • Dr Carlos Alemparte GSK Tres Cantos, Spain
  • Prof Ed Tate Imperial College London and Francis Crick Institute, United Kingdom
  • Dr Neil Norcross University of Dundee, United Kingdom
  • Dr Beatriz Díaz Hernández GSK Tres Cantos, Spain
  • Dr Brice Campo MMW, Switzerland
  • Dr Tim Miles GSK Tres Cantos, Spain
  • Dr Gavin Whitlock DNDi, Switzerland
  • Dr Advait Nagle Genomics Institute of the Novartis Research Foundation, United States
  • Dr Michael Pollastri Northeastern University, United States
  • Prof Johan Neyts University of Leuven, Belgium
  • Dr Steve Ward Gates Foundation, United States
  • Dr Wei Zhu Roche, China
  • Dr Stephane Jeanmart Syngenta, Switzerland

Sponsorship & supporting organisations
GlaxoSmithKline
Venue
GlaxoSmithKline, Tres Cantos, Madrid, Spain

GlaxoSmithKline, Tres Cantos, Madrid, Spain, Parque Tecnológico de Madrid, Calle de Severo Ochoa, Tres Cantos, Madrid, 2, 28760, Spain

Committee
Organised by
SCI's Fine Chemicals Group​
RSC Biological and Medicinal 91AV Sector
 
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*